Stickings Paul, Rigsby Peter, Coombes Laura, Malik Kiran, Matejtschuk Paul, Sesardic Dorothea
Division of Bacteriology, National Institute for Biological Standards and Control, Health Protection Agency, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, United Kingdom.
Biologicals. 2010 Sep;38(5):529-38. doi: 10.1016/j.biologicals.2010.04.001. Epub 2010 Jun 19.
We present the results of a collaborative study for the characterization of a preparation of diphtheria toxoid adsorbed, and its calibration in terms of the 3rd International Standard (IS) for Diphtheria Toxoid Adsorbed. Calibration was performed using established World Health Organization (WHO) and European Pharmacopoeia (Ph. Eur.) protection models. Two candidate toxoid preparations were included in the study, one of which was adopted as a replacement Ph. Eur. Biological Reference Preparation (BRP, batch 4) in February 2009. The second candidate preparation was found to have a unitage of 213 IU/ampoule based on the calibration by in vivo bioassay in 19 laboratories in 16 countries, and was established as the 4th IS for Diphtheria Toxoid Adsorbed by the WHO Expert Committee on Biological Standardization (ECBS) in October 2009. The study also assessed performance of the replacement standard in mouse and guinea pig serological assays which are used as alternative procedures for diphtheria potency testing. Participants tested both candidate preparations and potency was expressed in relative terms only. Results suggest that the replacement standard is suitable for use as the reference vaccine in serological assays and that the Vero cell assay may be suitable for calibration of future replacement standards.
我们展示了一项合作研究的结果,该研究旨在对白喉类毒素吸附制剂进行特性鉴定,并根据白喉类毒素吸附第3国际标准(IS)对其进行校准。校准使用了世界卫生组织(WHO)和欧洲药典(Ph. Eur.)既定的保护模型。该研究纳入了两种候选类毒素制剂,其中一种于2009年2月被用作替代欧洲药典生物参考制剂(BRP,第4批)。基于16个国家19个实验室的体内生物测定校准,发现第二种候选制剂的效价为213 IU/安瓿,并于2009年10月被世界卫生组织生物标准化专家委员会(ECBS)确立为白喉类毒素吸附第4国际标准。该研究还评估了替代标准在小鼠和豚鼠血清学检测中的性能,这些检测用作白喉效价检测的替代方法。参与者对两种候选制剂都进行了检测,效价仅以相对值表示。结果表明,替代标准适用于血清学检测中作为参考疫苗,并且Vero细胞检测可能适用于未来替代标准的校准。